Showing results (71-80 of 125) with videos related to
Sort By:
Pageof 13
Clinical Breast Cancer|January 5, 2016
Biomarkers That Predict Sensitivity to Heat Shock Protein 90 InhibitorsKomal Jhaveri, Sarat Chandarlapaty, Neil Iyengar, et al.Journal of Geriatric Oncology|January 30, 2014
A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901Jeanne S Mandelblatt, Solomon B Makgoeng, Gheorghe Luta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group BBlase N Polite, Constance Cirrincione, Gini F Fleming, et al.Annals of Surgical Oncology|November 7, 2015
Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020)Faina Nakhlis, Lauren Gilmore, Rebecca Gelman, et al.Breast Cancer Research : BCR|August 3, 2017
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancerKomal Jhaveri, Rui Wang, Eleonora Teplinsky, et al.Breast Cancer Research and Treatment|October 6, 2016
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)Mehra Golshan, Constance T Cirrincione, William M Sikov, et al.Breast Cancer Research and Treatment|June 15, 2006
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806Mercedes Rincon, Gloria Broadwater, Lyndsay Harris, et al.Journal of Cancer Survivorship : Research and Practice|June 12, 2014
Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901Leigh Anne Faul, Gheorghe Luta, Vanessa Sheppard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)Hope S Rugo, William T Barry, Alvaro Moreno-Aspitia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancerAna M Gonzalez-Angulo, Katherine Stemke-Hale, Shana L Palla, et al.Pageof 13